Health Robotics Continues Worldwide Distribution Channel Expansion With Gamida MedEquip Ltd. in Israel

Mar 14, 2011, 09:00 ET from Health Robotics

BOZEN, Sud-Tirol, Italy, March 14, 2011 /PRNewswire/ -- Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd. This partnership represents Health Robotics' market entry into its 17th new country over the past 20 months, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

"Gamida is very pleased to offer Health Robotics' unique technology to Israel's top medical centers, which have been awaiting for quite a long time to benefit from these technology solutions, much like Oncology patients and Pharmacological teams all over the world have been enjoying with Health Robotics' CytoCare since 2007", stated Moshe Reuveni, Gamida MedEquip's Managing Director.

CytoCare is the first and only robotic system proven to work anywhere in the world for the safe and sterile preparation of Hazardous Intravenous Admixtures, including Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. With 67 installations currently under contract in 17 countries, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents. While several companies attempted the development of Chemotherapy Robotics as far back as 22 years ago[1], Cytocare is still the only robot that has been able to break the entry-barrier into the Intravenous Chemotherapy Automation Sector.

"Since I personally witnessed two years ago at Hadassah Medical Center the outstanding charity-based care delivered to both Palestinian and Israeli Cancer patients, it has been a long time coming for Health Robotics to be in a position to finally deliver our unique technology to tertiary healthcare centers in Israel such as Hadassah and Sheba Medical Center, which had both expressed high interest in our world-leading products a couple of years ago. After an unusually arduous and time-consuming process to find a service partner in Israel, thanks to Gamida, finally Health Robotics is able to deliver our products and services in Israel. My final selection of Gamida over Teva, Lapidot, and several other Israeli-based companies that had entered into negotiations for Health Robotics' exclusive distribution rights in Israel puts an end to a 2-year period of waiting by Israel's top medical centers", stated Gaspar DeViedma, Health Robotics' Executive Vice President.

    ---------------------------------
    [1] Am J Hosp Pharm 46(11): 2286-93 1989

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing over 175 hospital installations in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(R) and i.v.STATION(R) ONCO [hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R) [workflow engine for manual compounding], MEDarchiver(R) [life-critical clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com

About Gamida Medical Equipment:

Gamida, an ISO9002 certified company, was established in 1989 and provides products and services to professionals & decision makers in the health care field in Israel, so that they can improve their health care performance and fulfill their purpose for improving quality of life. Its main areas of activities include Operating Room, Cardiology, Intensive Care, Radiology, Oncology, Clean Rooms, and Drug Delivery Systems to all of the hospitals and other healthcare institutions in Israel, including the Ministry of Health, the Armed Forces, Sick-Fund Health Services and the private sector. Gamida acts as distributor and service provider in Israel for a growing number of prominent international corporations, including: St. Jude Medical, VWR Scientific Products Division, Cardinal Health, Smiths Medical, Integra, Jostra, Scanlan, Medical Concept Development, Derma Sciences, Luxtec, Levitronix , OptiMed, Thoratec, Truetest, Talley Medical, Hemochron, CeloNova, and MDG Medical.

    For additional information, please contact:

    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372


SOURCE Health Robotics